Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KERX | AMGN | VRTX | REGN | BMY |
| Company | Keryx Biopharm Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 3.44 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 3.46 | 277.25 | 402.48 | 901.44 | 44.47 |
| Low | 2.96 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 3.36 | 276.24 | 400.45 | 902.06 | 44.04 |
| Change | -0.07 | +2.30 | +7.64 | +11.40 | +0.10 |
| % Change | -2.04% | +0.84% | +1.94% | +1.28% | +0.23% |
| Volume | 2,596,000 | 903,670 | 513,477 | 204,383 | 7,268,663 |
| 20-Day Average Volume | 1,773,160 | 2,168,536 | 960,345 | 456,430 | 13,740,970 |
| Previous Close | 3.43 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.97 | 269.61 | 398.77 | 908.85 | 48.21 |
| 20-Day Raw Stochastic | 85.58% | 91.04% | 39.34% | 26.14% | 4.63% |
| 20-Day Relative Strength | 57.59% | 51.34% | 45.67% | 40.32% | 28.11% |
| Weighted Alpha | -32.40 | +13.64 | +13.74 | +16.17 | -36.42 |
| Today's Opinion | N/A | 24% Sell | 8% Buy | 8% Buy | 88% Sell |
| Previous Opinion | N/A | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | N/A | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.53% since 12/04/18 | +1.01% since 04/24/24 | -0.31% since 04/24/24 | -0.95% since 04/24/24 | -9.71% since 04/24/24 |
| Low | 2.95 on 12/06/18 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 3.51 on 12/11/18 | 277.24 on 05/01/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | +16.26% since 11/12/18 | -2.57% since 04/01/24 | -4.98% since 04/01/24 | -7.36% since 04/01/24 | -16.75% since 04/01/24 |
| Low | 2.47 on 11/21/18 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 3.51 on 12/11/18 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | +12.37% since 09/12/18 | -15.04% since 02/01/24 | -7.92% since 02/01/24 | -6.25% since 02/01/24 | -9.36% since 02/01/24 |
| Low | 2.47 on 11/21/18 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 3.65 on 11/09/18 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -33.60% since 06/12/18 | +5.72% since 11/01/23 | +8.17% since 11/01/23 | +13.48% since 11/01/23 | -13.97% since 11/01/23 |
| Low | 2.47 on 11/21/18 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 5.30 on 06/20/18 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 343,997 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 102,380 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 60,640,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -163,440,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 28,040,000 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -17,000,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 2.35 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 02/07/18 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 02/06/19 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |